Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Allergy, 2024
Allergen‐specific B cell responses in oral immunotherapy‐induced desensitization, remission, and natural outgrowth in cow's milk allergy

Satitsuksanoa P., van de Veen W., Tan G. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyCell Culture Supernatant

Frontiers in Immunology, 2024
Exploring causal correlations between circulating cytokines and atopic dermatitis: a bidirectional two-sample Mendelian randomization study

Xuan Z., Chen X., Zhou W. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyPlasma

Journal of Proteome Research, 2024
Characterization of Inflammatory Mediators and Metabolome in Interstitial Fluid Collected with Dermal Open Flow Microperfusion before and at the End of Dupilumab Treatment in Atopic Dermatitis

Monedeiro F., Ehall B., Tiffner K. et al.

Olink Target 48Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyPlasmaInterstitial Fluid

Nature, 2024
Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus

Law C., Wacleche V., Cao Y. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Nature Aging, 2024
Blood protein assessment of leading incident diseases and mortality in the UK Biobank

Gadd D., Hillary R., Kuncheva Z. et al.

Olink Explore 3072/384AgingPatient StratificationPlasma

Experimental Dermatology, 2024
Eosinophils in hidradenitis suppurativa patients exhibit pro‐inflammatory traits, implicating a potential pathogenic role in the disease

Renert‐Yuval Y., Gonzalez J., Garcet S. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyCell Culture Supernatant

Nature Communications, 2024
Start codon variant in LAG3 is associated with decreased LAG-3 expression and increased risk of autoimmune thyroid disease

Saevarsdottir S., Bjarnadottir K., Markusson T. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesCross-platform ValidationPlasma

International Journal of Surgery, 2024
Exploring potential plasma drug targets for cholelithiasis through multiancestry Mendelian randomization

Liu X., Shi L., Zhang S. et al.

Olink Explore 3072/384Other Diseases & SyndromesPathophysiologyPlasma

Neurology, 2024
Prediction of Future Parkinson Disease Using Plasma Proteins Combined With Clinical-Demographic Measures

You J., Wang L., Wang Y. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

Brain, Behavior, and Immunity, 2024
Spinal cord injury disrupts plasma extracellular vesicles cargoes leading to neuroinflammation in the brain and neurological dysfunction in aged male mice

Lei Z., Krishnamachary B., Khan N. et al.

Olink Target 96 MouseNeurologyAgingPathophysiologyEV Lysate

Biomedical Chromatography, 2024
Plasma metabolites and inflammatory proteins profiling predict outcome of Fufang Duzhong Jiangu granules treating Kashin–Beck disease

Deng X., Niu H., Zhang Q. et al.

Olink Target 96Other Diseases & SyndromesPatient StratificationPlasma

JCI Insight, 2024
Protein biomarker signature in patients with spinal and bulbar muscular atrophy

Tebbenkamp A., Huggett S., Lombardi V. et al.

Olink Explore 3072/384Olink Target 96 MouseNeurologyPathophysiologyPlasmaMouse PlasmaSerum

Pediatric Allergy and Immunology, 2024
Multiarray screening identifies plasma proteins associated with Th17 cell differentiation and viral defense in coincident asthma and obesity

Manell H., Tsolakis N., Janson C. et al.

Olink Target 96Metabolic DiseasesImmunological & Inflammatory DiseasesPathophysiologyPlasma

Frontiers in Immunology, 2024
Plasma proteins and psoriatic arthritis: a proteome-wide Mendelian randomization study

Zhao H., Zhou Y., Wang Z. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyPatient StratificationPlasma

Science Translational Medicine, 2024
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection

Peluso M., Ryder D., Flavell R. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyPlasma

International Archives of Occupational and Environmental Health, 2024
Longitudinal changes in cardiovascular disease–related proteins in welders

Dauter U., Gliga A., Albin M. et al.

Olink Target 96CVDEnvironmental Health & ToxicologyPathophysiologySerum

Critical Care Explorations, 2024
Can Biomarkers Correctly Predict Ventilator-associated Pneumonia in Patients Treated With Targeted Temperature Management After Cardiac Arrest? An Exploratory Study of the Multicenter Randomized Antibiotic (ANTHARTIC) Study

Deye N., Le Gouge A., François B. et al.

Olink Target 96Infectious DiseasesPatient StratificationSerum

Aging Cell, 2024
SCARF2 is a target for chronic obstructive pulmonary disease: Evidence from multi‐omics research and cohort validation

Wang S., Yue Y., Wang X. et al.

Olink Explore 3072/384Respiratory DiseasesCross-platform ValidationPlasma

Vaccines, 2024
Long-Lasting Enhanced Cytokine Responses Following SARS-CoV-2 BNT162b2 mRNA Vaccination

Cabău G., Badii M., Mirea A. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Skin Research and Technology, 2024
The causal relationship between immune cells mediating FIT3L, CCL4, OSM, and skin‐derived deteriorated tumors

Gong W., Zhou J., Hou Y. et al.

Olink Target 96OncologyPathophysiologyPlasma

2846 publications